F. Manganelli et al., Influence of left ventricular cavity size on clinical presentation in hypertrophic cardiomyopathy, AM J CARD, 83(4), 1999, pp. 547-552
Citations number
24
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
The aim of this study was to assess whether left ventricular (LV) cavity si
ze relates to functional impairment and syncope in patients with hypertroph
ic cardiomyopathy (HC). LV diastolic dysfunction influences functional limi
tation in HC. A reduced LV end-diastolic dimension may underlie impaired di
astolic properties and be implicated in hemodynamic syncope. Eighty-two con
secutive patients with HC (off drugs, in sinus rhythm) underwent echocardio
graphy to measure LV end-diastolic dimension in the short-axis view (indexe
d to the body surface area) and radionuclide angiography (n = 50) to calcul
ate peak filling rate (normalized to stroke counts/s). Patients in New York
Heart Association functional classes II to IV had smaller LV end-diastolic
dimension (23.2 +/- 2.6 vs 25.5 +/- 2.5 mm/M-2, p = 0.0001) and lower peak
filling rate (4.3 +/- 1.4 vs 5.1 +/- 1.3 stroke counts/s, p = 0.036) than
those in New York Heart Association class I. LV end-diastolic diameter was
correlated to peak filling rate (r = 0.37; p = 0.008). The most potent pred
ictors of functional limitation were LV end-diastolic dimension (relative r
isk [RR] 0.63, confidence interval [CI] 0.45 to 0.88; p = 0.008), age (RR 1
.09, CI 1.03 to 1.17; p = 0.003), and LV thickness score (RR 1.08, CI 1.02
to 1.13; p = 0.003). LV cavity size was smaller in patients with functional
limitation irrespective of obstruction and hypertrophy. Patients with diff
ered from those without a history of syncope for a smaller LV end-diastolic
dimension (23.2 +/- 2.5 vs 25.0 +/- 2.7 mm/M-2, p = 0.008), which was the
only independent predictor of syncope (RR 0.77, CI 0.63 to 0.95; p = 0.013)
. Thus, a small LV cavity size is associated with functional limitation and
history of syncope in HC. (C) 1999 by Excerpta Medica, Inc.